Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Retinoid targets for apoptosis induction

Oncogene volume 22, pages 9058–9062 (2003)Cite this article

Abstract

Certain synthetic retinoid-related molecules induce apoptosis in cancer cells through a novel mechanism of retinoid action that is independent of the nuclear retinoid receptors. These compounds target protein kinases and protein phosphatases to trigger signal transduction pathways that lead to apoptosis. Whereas retinoid agonists such as CD437 activate stress kinases via inhibition of the phosphatase MKP-1, the retinoid antagonist MX781 inhibits the survival kinase IKK. These retinoid-mediated signaling pathways converge at the mitochondria, where they cause the release of cytochrome c and subsequent Apaf-1-dependent activation of caspases. Identification of the retinoid targets that mediate their apoptotic activity will enhance our understanding of the mechanism of this novel retinoid action, to allow appropriate optimization of currently available compounds to advance into the clinic as novel anticancer agents.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Adachi H, Adams A, Hughes FM, Zhang J, Cidlowski JA and Jetten AM . (1998). Cell Death Differ., 5, 973–983.

  • Bang YJ, Kwon JH, Kang SH, Kim JW and Yang YC . (1998). Biochem. Biophys. Res. Commun., 250, 43–47.

  • Bayon Y, Ortiz MA, Lopez-Hernandez FJ, Gao F, Karin M, Pfahl M and Piedrafita FJ . (2003). Mol. Cell. Biol., 23, 1061–1074.

  • Belzacq AS, El Hamel C, Vieira HL, Cohen I, Haouzi D, Metivier D, Marchetti P, Brenner C and Kroemer G . (2001). Oncogene, 20, 7579–7587.

  • Camps M, Nichols A and Arkinstall S . (1999). FASEB J., 14, 6–16.

  • Chen Y, Buck J and Derguini F . (1999). Cancer Res., 59, 3985–3990.

  • Degos L and Wang ZY . (2001). Oncogene, 20, 7140–7145.

  • Delia D, Aiello A, Formelli F, Fontanella E, Costa A, Miyashita T, Reed JC and Pierotti MA . (1995). Blood, 85, 359–367.

  • Delia D, Aiello A, Lombardi L, Pellici PG, Grignani F, Formelli F, Menard S, Costa A, Veronesi U and Pierotti MA . (1993). Cancer Res., 53, 6036–6041.

  • Delia D, Aiello A, Meroni L, Nicolini M, Reed JC and Pierotti MA . (1997). Carcinogenesis, 18, 943–948.

  • Denkert C, Schmitt WD, Berger S, Reles A, Pest S, Siegert A, Lichtenegger W, Dietel M and Hauptmann S . (2002). Int. J. Cancer, 102, 507–513.

  • Donovan N, Becker EB, Konishi Y and Bonni A . (2002). J. Biol. Chem., 277, 40944–40949.

  • Erdreich-Epstein A, Tran LB, Bowman NN, Wang H, Cabot MC, Durden DL, Vlckova J, Reynolds CP, Stins MF, Groshen S and Millard M . (2002). J. Biol. Chem., 277, 49531–49537.

  • Fanjul AN, Delia D, Pierotti MA, Rideout D, Qiu J and Pfahl M . (1996). J. Biol. Chem., 271, 22441–22446.

  • Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T and Alnemri ES . (2002). J. Biol. Chem., 277, 13430–13437.

  • Hail Jr N, Youssef EM and Lotan R . (2001). Cancer Res., 61, 6698–6702.

  • Hoyos B, Imam A, Chua R, Swenson C, Tong GX, Levi E, Noy N and Hammerling U . (2000). J. Exp. Med., 192, 835–845.

  • Hoyos B, Imam A, Korichneva I, Levi E, Chua R and Hammerling U . (2002). J. Biol. Chem., 277, 23949–23957.

  • Hsieh T, Ng C and Wu JM . (1995). Biochem. Mol. Biol. Int., 37, 499–506.

  • Hsu CA, Rishi AK, Su-Li X, Gerald TM, Dawson MI, Schiffer C, Reichert U, Shroot B, Poirer GC and Fontana JA . (1997). Blood, 89, 4470–4479.

  • Imam A, Hoyos B, Swenson C, Levi E, Chua R, Viriya E and Hammerling U . (2001). FASEB J., 15, 28–30.

  • Johnson DE . (2000). Leukemia, 14, 1695–1703.

  • Kalemkerian GP, Slusher R, Ramalingam S, Gadgeel S and Mabry M . (1995). J. Natl. Cancer Inst., 87, 1674–1680.

  • Karin M, Cao Y, Greten FR and Li ZW . (2002). Nat. Rev. Cancer, 2, 301–310.

  • Korichneva I and Hammerling U . (1999). J. Cell Sci., 112 (Part 15), 2521–2528.

  • Lassus P, Opitz-Araya X and Lazebnik Y . (2002). Science, 297, 1352–1354.

  • Li H, Kolluri SK, Gu J, Dawson MI, Cao X, Hobbs PD, Lin B, Chen G-Q, Lu J, Lin F, Xie Z, Fontana JA, Reed JC and Zhang X . (2000). Science, 289, 1159–1164.

  • Li Y, Lin B, Agadir A, Liu R, Dawson MI, Reed JC, Fontana JA, Bost F, Hobbs PD, Zheng Y, Chen G-Q, Shroot B, Mercola D and Zhang X . (1998). Mol. Cell. Biol., 18, 4719–4731.

  • Liu Y, Lee M-O, Wang H-G, Li Y, Hashimoto Y, Klaus M, Reed JC and Zhang X . (1996). Mol. Cell. Biol., 16, 1138–1149.

  • Lopez-Hernandez FJ, Ortiz MA, Bayon Y and Piedrafita FJ . (2003). Mol. Cancer Ther., 2, 255–263.

  • Lopez-Hernandez FJ, Ortiz MA, Bayon Y and Piedrafita FJ . (2003). Cell Death Diff., (in Press).

  • Lu XP, Fanjul AN, Picard N, Pfahl M, Rungta D, Nared-Hood K, Carter B, Piedrafita FJ, Tang S, Fabbrizio E and Pfahl M . (1997). Nat. Med., 3, 686–690.

  • Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P, Wishnow K, Kaplan I, Stork PJ and Loda M . (1997). Lab. Invest., 76, 37–51.

  • Marchetti P, Zamzami N, Joseph B, Schraen-Maschke S, Mereau-Richard C, Costantini P, Metivier D, Susin SA, Kroemer G and Formstecher P . (1999). Cancer Res., 59, 6257–6266.

  • Maundrell K, Antonsson B, Magnenat E, Camps M, Muda M, Chabert C, Gillieron C, Boschert U, Vial-Knecht E, Martinou J-C and Arkinstall S . (1997). J. Biol. Chem., 272, 25238–25242.

  • Merritt G, Aliprandis ET, Prada F, Rigas B and Kashfi K . (2001). Cancer Lett., 164, 15–23.

  • Mologni L, Ponzanelli I, Bresciani F, Sardiello G, Bergamaschi D, Gianni M, Reichert U, Rambaldi A, Terao M and Garattini E . (1999). Blood, 93, 1045–1061.

  • O'Connell MJ, Chua R, Hoyos B, Buck J, Chen Y, Derguini F and Hammerling U . (1996). J. Exp. Med., 184, 549–555.

  • Oridate N, Suzuki S, Higuchi M, Mitchell MF, Hong WK and Lotan R . (1997). J. Natl. Cancer Inst., 89, 1191–1198.

  • Ortiz MA, Lopez-Hernandez FJ, Bayon Y, Pfahl M and Piedrafita FJ . (2001). Cancer Res., 61, 8504–8512.

  • Paroni G, Henderson C, Schneider C and Brancolini C . (2002). J. Biol. Chem., 277, 15147–15161.

  • Piedrafita FJ and Pfahl M . (1997). Mol. Cell. Biol., 17, 6348–6358.

  • Ponzanelli I, Gianni M, Giavazz R, Garofalo A, Nicoletti I, Reichert U, Erba E, Rambaldi A, Terao M and Garattini E . (2000). Blood, 95, 2672–2682.

  • Ponzoni M, Bocca P, Chiesa V, Decensi A, Pistoia V, Raffaghello L, Rozzo C and Montaldo PG . (1995). Cancer Res., 55, 853–861.

  • Rishi AK, Sun RJ, Gao Y, Hsu CK, Gerald TM, Sheikh MS, Dawson MI, Reichert U, Shroot B, Fornace Jr AJ, Brewer G and Fontana JA . (1999). Nucleic Acids Res., 27, 3111–3119.

  • Sakaue M, Adachi H and Jetten AM . (1999). Mol. Pharmacol., 55, 668–676.

  • Simeone AM, Ekmekcioglu S, Broemeling LD, Grimm EA and Tari AM . (2002). Mol. Cancer Ther., 1, 1009–1017.

  • Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR and Martin SJ . (1999). J. Cell Biol., 144, 281–292.

  • Sun SY, Li W, Yue P, Lippman SM, Hong WK and Lotan R . (1999a). Cancer Res., 59, 2493–2498.

  • Sun SY, Yue P, Chandraratna RA, Tesfaigzi Y, Hong WK and Lotan R . (2000). Mol. Pharmacol., 58, 508–514.

  • Sun SY, Yue P, Shroot B, Hong WK and Lotan R . (1999b). Oncogene, 18, 3894–3901.

  • Sun SY, Yue P, Wu GS, El Deiry WS, Shroot B, Hong WK and Lotan R . (1999c). Cancer Res., 59, 2829–2833.

  • Suzuki S, Higuchi M, Proske RJ, Oridate N, Hong WK and Lotan R . (1999). Oncogene, 18, 6380–6387.

  • Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA and Davis RJ . (2000). Science, 288, 870–874.

  • Vicent S, Mercedes G, Lopez-Picazo J, Lozano M, Toledo G, Manzano R and Montuenga L . (2002). Proc. Am. Assoc. Cancer Res., 43, 360.

  • Wang CY, Cusack JCJ, Liu R and Baldwin ASJ . (1999). Nat. Med., 5, 412–417.

  • Wang H, Cheng Z and Malbon CC . (2003). Cancer Lett., 191, 229–237.

  • Wang H, Maurer BJ, Reynolds CP and Cabot MC . (2001). Cancer Res., 61, 5102–5105.

  • Wang TT and Phang JM . (1996). Cancer Lett., 107, 65–71.

  • Wu JM, DiPietrantonio AM and Hsieh TC . (2001). Apoptosis, 6, 377–388.

  • Yamamoto K, Ichijo H and Korsmeyer S . (1999). Mol. Cell. Biol., 19, 8469–8478.

  • Yang J and Richmond A . (2001). Cancer Res., 61, 4901–4909.

  • Zang Y, Beard RL, Chandraratna RA and Kang JX . (2001). Cell Death Differ., 8, 477–485.

  • Zhang Y, Huang Y, Rishi AK, Sheikh MS, Shroot B, Reichert U, Dawson M, Poirer G and Fontana JA . (1999). Exp. Cell Res., 247, 233–240.

Download references

Author information

Authors and Affiliations

  1. Incyte San Diego, Inc., 10835 Altman Row, San Diego, 92121, CA, USA

    Magnus Pfahl

  2. Sidney Kimmel Cancer Center, San Diego, 92121, CA, USA

    Francisco Javier Piedrafita

Authors
  1. Magnus Pfahl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francisco Javier Piedrafita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Magnus Pfahl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pfahl, M., Piedrafita, F. Retinoid targets for apoptosis induction. Oncogene 22, 9058–9062 (2003). https://doi.org/10.1038/sj.onc.1207109

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207109

Keywords

This article is cited by

Search

Advanced search

Quick links